Z-0417-2015 Class II Terminated
FDA device recall Z-0417-2015 was initiated by Diagnostic Hybrids Inc on Oct 16, 2014 and is designated Class II. Reason for recall: Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented. The recall status is terminated (terminated Sep 3, 2015). Affected quantity: 171.
Recall details
- Product Type
- Devices
- Report Date
- Sep 9, 2015
- Initiation Date
- Oct 16, 2014
- Termination Date
- Sep 3, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 171
Product description
MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.
Reason for recall
Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.
Distribution pattern
Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.
Code information
Model Number A027; Lot Number 018186; (self-affixed, EDMA Code: 12 01 02 04 00; Complement Component Bb)
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0417-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026